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Abstract
Neural stem/progenitor cell (NSPC) transplantation is a promising therapy for spinal cord injury (SCI). However, little is
known about NSPC from the adult human spinal cord as a donor source. We demonstrate for the first time that multipotent
and self-renewing NSPC can be cultured, passaged and transplanted from the adult human spinal cord of organ transplant
donors. Adult human spinal cord NSPC require an adherent substrate for selection and expansion in EGF (epidermal growth
factor) and FGF2 (fibroblast growth factor) enriched medium. NSPC as an adherent monolayer can be passaged for at least 9
months and form neurospheres when plated in suspension culture. In EGF/FGF2 culture, NSPC proliferate and primarily
express nestin and Sox2, and low levels of markers for differentiating cells. Leukemia inhibitory factor (LIF) promotes NSPC
proliferation and significantly enhances GFAP expression in hypoxia. In differentiating conditions in the presence of serum,
these NSPC show multipotentiality, expressing markers of neurons, astrocytes, and oligodendrocytes. Dibutyryl cyclic AMP
(dbcAMP) significantly enhances neuronal differentiation. We transplanted the multipotent NSPC into SCI rats and show
that the xenografts survive, are post-mitotic, and retain the capacity to differentiate into neurons and glia. Together, these
findings reveal that multipotent self-renewing NSPC cultured and passaged from adult human spinal cords of organ
transplant donors, respond to exogenous factors that promote selective differentiation, and survive and differentiate after
transplantation into the injured spinal cord.
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Introduction
Despite advances in medical and surgical care, current clinical
therapies for spinal cord injury (SCI) are limited [1,2]. One
promising approach is cell transplantation to replace damaged
cells and promote neuroprotective and neuroregenerative repair.
Neural stem cells may be ideal candidates because they can self-
renew and are committed to the neural lineage such that they will
produce only neuronal and glial cells, and can also be pre-
differentiated in vitro along a specific lineage. Neural stem/
progenitor cells (NSPC) can be isolated from the developing and
adult CNS, and are expanded in vitro with mitogenic growth
factors such as EGF and FGF2 [3,4]. Human embryonic stem cell-
derived oligodendrocyte progenitor cells and fetal NSPC are
already in Phase 1 clinical trials. The use of adult stem cells avoids
the ethical issues of procurement from fetal or embryonic origin.
Also, adult stem cells show less oncogenic potential than fetal stem
cells or undifferentiated embryonic stem cells [5–8]. Spinal cord
derived NSPC are region-specific, and thus, may respond more
appropriately to the intrinsic micro-environment of the injured
spinal cord. Lower vertebrates such as urodele amphibians can
regenerate their spinal cord even after full transection. This is in
part due to the ependymal cells lining the central canal which
proliferate, migrate, and differentiate into neurons and glia and
regenerate the spinal cord [9,10]. Multipotent, self-renewing
NSPC can be isolated and cultured from the adult rodent spinal
cord when the cultured tissue includes regions of the central canal
[11,12]. We have shown that NSPC generated from the
periventricular region of the adult rat spinal cord primarily
differentiate into oligodendrocytes in vitro [11] and in vivo
[13,14]. Moreover, we and other groups have shown that
transplantation of adult rat spinal cord NPSC into SCI rats
promoted functional recovery [15–17].
Most experimental SCI studies use NSPC generated from
rodents because human stem cells are either not available or are
difficult to grow and grow slowly compared to rodent cells [18].
However, considerable species specific differences have been
reported [19–21]. Human NSPC have been isolated from fetal
brain and spinal cord from aborted fetuses [21–31] and from adult
brain from surgical biopsy specimens and post-mortem tissue [32–
34]. However, little is known about NSPC from the adult human
spinal cord. It has been reported that neurospheres generated from
human fetal spinal cord tissue more than 9.5 weeks of gestation
cannot be propagated long-term [23,26,31]. In 2008, primary
neurospheres were generated from the spinal cord of adult human
organ transplant donors but these precursors could not be
passaged to generate sufficient numbers of cells [35]. To our
knowledge, there are no previous reports of successful passaging
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Thus, this is the first study to show that self-renewing multipotent
NSPC can be passaged from adult human spinal cords of organ
transplant donors, and to demonstrate that these cells survive and
differentiate into both neurons and glia following transplantation
into rats with SCI.
Materials and Methods
Ethics statement
For the harvesting of human spinal cord tissue, approval was
obtained from the University Health Network Research Ethics
Board and from the Trillium-Gift of Life Foundation which
oversees organ donation in Ontario. All animal procedures were
approved by the animal care committee of the University Health
Network in accordance with the policies established in the Guide
to the Care and Use of Experimental Animals prepared by the
Canadian Council on Animal Care.
Harvesting of spinal cord tissue
Human spinal cord tissue was harvested from adult organ
transplant donors after the organs to be transplanted were
removed. Spinal cords were harvested from 11 donors, male and
female, ranging in age from 2 to 60 years old (Table 1). Generally,
one or two 3–6 cm segments of spinal cord from the upper
thoracic and/or mid-to-low thoracic levels were excised. The
spinal cord segments were removed in the operating room under
sterile conditions as soon as possible after cessation of circulation
and placed into cold 1x Hanks’ Balanced Salt Solution (HBSS)
(Gibco-Invitrogen) containing 2% penicillin-streptomycin (Sigma).
Culture of adult human spinal cord NSPC
The spinal cord was washed in 1x HBSS and the overlying
meninges were removed. Using microscissors and jeweller’s
forceps, the white matter and most of the grey matter were
removed leaving the periventricular region including the ependy-
mal, subependymal, and some grey matter tissue surrounding the
central canal. The dissected tissue was cut into 1 mm
3 pieces,
enzymatically dissociated in a solution containing 0.01% papain
and 0.01% DNase I (Worthington Biochemicals) for 1–2 hours at
37uC, and then mechanically dissociated into a cell suspension.
The cell suspension was centrifuged using a discontinuous density
gradient consisting of a 10 mg/ml albumin-ovomucoid protein
inhibitor (Worthington Biochemicals) to remove cell membrane
fragments. Cells were resuspended in serum-free medium (SFM)
consisting of Neurobasal-A medium (Gibco-Invitrogen) supple-
mented with B27 neural supplement (Gibco-Invitrogen), 2 mM L-
glutamine (Gibco-Invitrogen), 100 mg/ml penicillin-streptomycin
(Gibco-Invitrogen), and hormone mix consisting of 1:1 DMEM/F-
12 (Gibco-Invitrogen), 0.6% glucose (Sigma), 25 mg/ml insulin
(Sigma), 100 mg/ml transferrin (Sigma), 5 mM HEPES (Sigma),
3 mM sodium bicarbonate (Sigma), 30 nM sodium seleniate
(Sigma), 10 mM putrescine (Sigma), and 20 nM progesterone
(Sigma). The SFM was supplemented with 20 ng/ml human
recombinant epidermal growth factor (EGF, Sigma), 20 ng/ml
human recombinant fibroblast growth factor-2 (FGF2, Sigma),
and 2 mg/ml heparin (Sigma). Cells were seeded in the growth
factor supplemented medium at a density of 10
5 cells/well into 6-
well culture plates (Nunc) coated with matrigel (BD Biosciences
Inc.). We also examined a variety of other adherent substrates such
as fibronectin, collagen type I, and poly-D-lysine/laminin (all from
BD Biosciences Inc.). These substrates were also found to be
effective for adherence of these cells, however, matrigel was used
in all the experiments described. One week later, half of the
culture medium was replaced with fresh growth factor supple-
mented SFM twice weekly. One to two weeks later, the culture
medium was replaced twice a week with fresh SFM supplemented
with growth factors, and cells were subcultured with Accutase
before reaching confluence between 4-8 weeks. Cultures were
normally incubated at 37uC, 5% CO2, 20% O2 (normoxia). In
initial experiments, we also examined the effects of 10% BIT 9500
serum (StemCell Technologies, Vancouver BC) and 10 ng/ml
leukemia inhibitory factor (LIF) (Millipore, Temecula, CA) in
growth factor enriched SFM to promote the expansion of NSPC
cultured as suspension cultures in uncoated tissue culture flasks.
Karyotype analysis was conducted by The Centre for Applied
Genomics at the Hospital for Sick Children (Toronto ON).
Assessment of growth factor dependance, neurosphere
formation, effects of LIF and hypoxia
To examine growth factor dependance, the same concentration
of cells was plated onto matrigel coated wells in SFM described
above in either the absence of growth factors, in 20 ng/ml EGF
alone, or in 20 ng/ml FGF2 + 2 mg/ml heparin. Heparin was
always added when FGF2 was present since it functions as a
cofactor for FGF2. Cells were also cultured as free-floating
neurospheres in SFM supplemented with EGF/FGF2. To
evaluate the formation of neurospheres, NSPC were seeded at
varying densities (,10 cells/ml, 100 cells/ml, 1000 cells/ml, and
10,000 cells/ml) in growth factor supplemented medium in
uncoated tissue culture flasks. The flasks were placed back in the
incubator and not moved until 7d later when they were examined
for neurosphere formation. To examine the effects of LIF, parallel
plates were prepared at the time of isolation and 10 ng/ml LIF
(Millipore) was added to each well containing the EGF/FGF2
supplemented medium. LIF was replaced with each feeding. To
examine the effects of hypoxia, cultures were incubated from the
time of isolation in a reduced oxygen (3.5% O2,5 %C O 2)
incubator at 37uC. The phenotypic expression pattern of NSPC in
proliferating culture conditions was assessed by plating cells or
neurospheres onto matrigel coated wells and immunostaining as
described below.
Differentiation of spinal cord NSPC
NSPC were assessed for multipotentiality by plating onto
matrigel in SFM with 1% fetal bovine serum (FBS) in the absence
Table 1. Donors for harvesting of human spinal cord.
Donor Age Gender Time to Harvesting
H1 60 F 7 hrs
H2 52 F 6 hrs
H3 57 M 4 hrs
H4 53 F 3.5 hrs
H5 21 M 7 hrs
H6 50 F 6 hrs
H7 51 F 4 hrs
H8 2 M 3 hrs
H9 16 F 4 hrs
H10 43 M 3.75 hrs
H11 16 M 3 hrs
Summary of donor age, gender, and time to completion of harvesting (time
from cardiac cessation to spinal cord harvesting).
doi:10.1371/journal.pone.0027079.t001
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assess the effect of exogenous factors on NSPC differentiation,
NSPC were plated in EGF/FGF2 medium at a density of 10
5
cells/well into 24-well culture plates coated with matrigel. Cultures
were incubated for 1 week, and then the medium was replaced
with one of the following factors in SFM: 40 and 100 ng/ml
PDGF-AA (Peprotech) to promote oligodendrocyte differentiation,
and 1 and 4 mM dbcAMP (Sigma-Aldrich) to promote neuronal
differentiation. Controls included 1% FBS and SFM. Cultures
were incubated at 37uC for an additional 4 weeks and the media
changed every week. The phenotypic expression pattern of NSPC
in differentiating culture conditions was examined by immuno-
staining as described below. The total number of cells counted
ranged from 180 – 400 cells per marker.
Immunocytochemistry
Cultures were fixed with 4% paraformaldehyde (PF) in 0.1 M
phosphate buffered saline (PBS) and washed with PBS. Cultures
were blocked with 10% normal goat serum with 0.3% Triton-X
100 and depending on the antibody with 1.5% bovine serum
albumin for 1 hr at room temperature, and then incubated with
the primary antibody overnight at 4uC. The following primary
antibodies were used: nestin (1:2000; Millipore, Temecula, CA) for
neural stem/progenitor cells; Ki67 (1:100; Novocastra Laborato-
ries, Newcastle, UK) for proliferating cells; Sox2 (1:1000;
Millipore) a transcription factor for precursor cells; GFAP
(1:2000; Dako, Burlington, ON) for astrocytes; RC1 (1:1000;
Developmental Studies Hybridoma Bank, Iowa City, IA) for radial
glia; O4 (1:1000; Millipore) for oligodendrocyte progenitor cells;
CNPase (1:500; Covance, Emeryville, CA) for oligodendrocytes;
bIII-tubulin (1:2000; Covance) for neuronal progenitor cells; and
NF200 (1:1000; Sigma, St. Louis, MS) for neurons. Cultures were
washed with 0.1 M PBS and then incubated with fluorescent Alexa
488 or 568 secondary antibody (1:500; Invitrogen) for 1 hr,
washed with PBS, and incubated in Hoechst (Sigma) to
counterstain the nuclei. Species specific non-immune IgG and
omission of primary antibody was used as negative controls. In
addition, NS1 serum (Developmental Studies Hybridoma Bank)
was used as a negative control for RC1 staining. Immunofluores-
cent staining was examined using a Nikon Eclipse TE 300
microscope.
Compression SCI and transplantation
Adult female Wistar rats (Charles River, St. Constant, QC, 150-
200g) were anesthetized by inhalation of 5% isofluorane which
was reduced to 2% during surgery, in combination with a mixture
of nitrous oxide and oxygen (1:2, v/v). With the aid of an
operating microscope, the spinal cord was exposed by laminec-
tomy at the T8-T9 vertebral level, and a clip impact-compression
injury was made with a 26g force for 1 minute according to the
method of Rivlin and Tator [36], a clinically relevant SCI model.
One week later, the lesion site was re-exposed, and adult human
spinal cord NSPC cultured between 31 to 89 days in vitro were
stereotactically injected using a Hamilton syringe with a 32 gauge
customized needle and a motorized microinjector (Model 780310;
Stoelting, IL). Using the motorized microinjector and operating
microscope, a 2.5 ml volume of NSPC containing 250,000 cells
was injected 1 mm into the cord at the midline, at 2 sites, 1 mm
rostral and caudal to the lesion epicentre. The needle was left in
place for an additional two minutes to prevent back-flow of cells.
To aid transplant survival and integration, animals were
immunosuppressed daily beginning 24 hrs before the day of
transplantation until sacrifice with 15 mg/kg of cyclosporine
(Sandimmune, Novartis, Dorval, QC, Canada) injected subcuta-
neously. Rats were sacrificed at 1 wk post-transplantation.
Tissue processing and immunohistochemistry
Animals were sacrificed with a lethal dose of sodium
pentobarbital, followed by transcardial perfusion with 4% PF in
0.1 M PBS, pH 7.4. The rostro-caudal segment of the spinal cord
1–1.5 cm in length encompassing the transplant sites was dissected
and the tissue cryoprotected in 30% sucrose. The tissue was
embedded in Shandon Cryomatrix compound (VWR Laborato-
ries, Mississauga, ON, Canada), and cryosectioned parasagittally
into 20 mm serial sections collected on Superfrost slides (Fisher
Scientific, Ottawa, ON, Canada). For immunostaining, sections
were rehydrated in 0.1M PBS and permeabilized and blocked with
0.3% Triton-X 100, 10% normal goat serum and 1% BSA for
1 hr at room temperature, and then incubated with the primary
antibody overnight at 4uC. The following primary antibodies were
used: hMito (1:100; Millipore) for human specific mitochondrial
antigen; hNuc (1:100; Millipore) for human specific nuclear
antigen; Ki67 (1:100; Novocastra) for proliferating cells; bIII-
tubulin (1:2000; Covance) for neuronal progenitor cells; GFAP
(1:2000; Dako) for astrocytes; and CC1 (1:1000; Calbiochem, San
Diego CA) for oligodendrocytes. For double-labelling, primary
antibodies were applied sequentially followed by species-specific
fluorescent-conjugated secondary antibodies for 1 hr at room
temperature, as described above. Slides were washed with PBS
and then coverslipped with Vectashield mounting medium
containing DAPI (49, 6-diamidino-2-phenyl-indole) (Vector Lab-
oratories) to counterstain the nuclei. Species specific non-immune
IgG was used as negative controls for each antibody, in addition to
tissue controls where available. Immunofluorescent tissue was
examined using a Zeiss LSM 510 confocal microscope.
Quantitative and statistical analysis
To quantify the phenotype of the cultured cells, the number of
immunopositive cells for each antibody was counted as a
percentage of Hoechst stained cells in 10-15 random fields (n =
3). Fluorescent cells were examined using a Nikon Eclipse TE 300
microscope, and images were captured using Nikon NIS Elements
BR v.3 image acquisition software (R & M Biometrics Inc.;
Nashville, TN). To quantify the number of transplanted cells,
every eighth section throughout the length of the excised segment
of rat spinal cord was analyzed, as we have previously described
[13,14]. All hNuc
+ cells containing a DAPI
+ nucleus were counted
and the total number of hNuc
+/DAPI
+ cells were multiplied by 8
to compensate for the sampling frequency. All data are presented
as mean 6 standard deviation. Data were analyzed using
SigmaStat v.3.11 software (Systat, Point Richmond, CA). One-
way analysis of variance (ANOVA) followed by the Bonferroni
post-hoc multiple group comparison was used to identify statistical
significance among treatments. Statistical significance was deter-
mined at the p,0.025 level.
Results
Adult human spinal cord precursors require an adherent
substrate for selection and expansion in EGF/FGF2
culture
We harvested spinal cord tissue from 11 organ donors, male and
female, 2 to 60 years of age (Table 1). From the first 3 donors, we
cultured the cells in suspension culture in growth factor enriched
SFM, using methods similar to our previous work with adult rat
spinal cord NSPC [11,13]. Using this approach, most of the
cultures consisted of aggregates of cells and debris (Fig. 1A) and
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obtained no viable cells after passaging these neurospheres. We
attempted to enhance expansion of the suspension cultures with
BIT 9500 serum (containing bovine serum albumin, transferrin,
and insulin) which was used successfully for the in vitro expansion
of hematopoietic stem cell cultures and neonatal human brain
progenitor cells [33,37,38], but we found no difference. We also
examined the effects of LIF, which was important for the self-
renewal of mouse embryonic stem cells and increased the rate of
proliferation of fetal neural stem cells [29,39–41]. Using a similar
concentration of 10 ng/ml LIF, we found no significant
differences in the suspension cultures. We also examined the
effect of hypoxia by reducing oxygen concentration to 3.5% vs.
20% O2 because hypoxia promoted expansion of human neonatal
Figure 1. Adult human spinal cord NSPC require an adherent substrate for selection and expansion in EGF/FGF2 culture. A, NSPC
were cultured from the time of isolation in uncoated tissue culture flasks. Phase contrast image shows primarily aggregates of debris and some cells
at 43div in hypoxic EGF/FGF2 culture containing LIF. B-C, In contrast, in the presence of an adhesive substrate, NSPC are selected in EGF/FGF2
medium and can be expanded continuously. B-C, NSPC cultured and passaged as a monolayer on matrigel for 41div (B) can also form neurospheres in
adherent culture (C). D-F, NSPC were cultured for 48div as an adherent monolayer on matrigel. In media containing only EGF (D) or FGF2 (E) fewer
cells survived compared to media containing both EGF and FGF2 (F). Both EGF and FGF2 were required for expansion and neurosphere formation.
Almost all NSPC expressed nestin (red) (G, 26div). NSPC also expressed Ki67 proliferating nuclear antigen (G, green in overlay; H, green; blue, Hoechst
nuclear counterstain). I, Cluster of neurospheres were removed from adherent culture (25div), plated on matrigel coated well in EGF/FGF2 medium,
and stained with nestin. Most NSPC expressed Sox2 (66div shown) (K, green; J, corresponding Hoechst staining of nuclei; L, merged).
doi:10.1371/journal.pone.0027079.g001
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mesencephalic neural precursors [44,45]. However, hypoxia did
not increase the number of neurospheres in suspension culture.
It is well known that NPSC can be cultured as free-floating
neurospheres in suspension [11,19,23,29,30,46]. However, NSPC
can also be cultured as an adherent monolayer, which has been
used to propagate tissue-specific stem cells without accompanying
differentiation [22,37,47,48]. For subsequent isolations, we
cultured the adult human spinal cord cells as an adherent
monolayer on matrigel coated wells in EGF/FGF2 supplemented
medium (Fig. 1B). This strategy was effective for selecting and
expanding the NSPC population. Thus, all cultures were viable
except for the first 3 isolations which could not be passaged. We
also examined several other adhesive substrates including
fibronectin, collagen type I, and poly-D-lysine/laminin. These
other substrates were also effective for adhesion, however matrigel
was used in all the experiments shown. In addition, myelin and
debris were removed when the medium was changed during the
feedings. As shown in Fig. 1C, sphere-like aggregates of cells also
formed from these adherent cultures. Both EGF and FGF2 were
required for NSPC expansion and formation of neurospheres
(Fig. 1). Fewer cells were present when the medium contained
either EGF or FGF2 alone (Fig. 1D-E). Although fewer cells were
observed under these conditions, it is possible that the multi-
potentiality or differentiation capacity of these cells is retained. We
generated NSPC as adherent monolayers for at least 9 months
involving approximately 10 passages. We generated cells from
spinal cord tissue harvested from organ donors if the time from
cardiac arrest to culture was 7 hours or less, and we have
generated sufficient numbers of NSPC for characterization and
transplantation. Karyotype analysis was performed to determine if
the genetic stability of the cells was maintained. Cells cultured for
4 months (P5) showed a normal diploid karyotype with no
chromosomal abnormalities (data not shown).
Adult human spinal cord cells express stem/progenitor
cell markers in proliferative conditions
In proliferative conditions in EGF/FGF2 culture, almost all
human spinal cord cells expressed nestin, a marker for neural
precursor cells (Fig. 1G, adherent NSPC; Fig. 1I, neurospheres).
These nestin positive cells proliferated in vitro, as shown with Ki67
immunostaining (Fig. 1G, double-labelled for nestin and Ki67;
Fig. 1H, corresponding Ki67 staining). Most cells also expressed
Sox2 (Fig. 1J–L), a transcription factor essential for embryonic
development, maintenance of pluripotency and self-renewal of
embryonic stem cells [49,50]. Also, Sox2 is a persistent marker for
multipotential neural stem cells at all stages of development [51,52].
To ascertain self-renewal and clonality, cells initially cultured as
an adherent monolayer were seeded at clonal conditions [53] in
suspension culture supplemented with EGF/FGF2 (Fig. 2A). It has
been shown that suspension cultures with low plating densities, as
used in the present study, and in the absence of movement during
the culture period will result in clonal neurospheres [53]. We found
that one week after seeding, small neurospheres formed (Fig. 2B).
When cells were seeded at a higher density, more neurospheres
formed and were larger (Fig. 2C–D). The formation of larger
spheres when cells were seeded at higher densities may be indicative
of cell aggregation. The inset in Fig. 2D shows a high magnification
image of a single neurospherewitha phase brightprofile and typical
ciliary projections (Fig. 2D, arrows). These neurospheres could be
propagated with passaging by dissociating with Accutase and
plating in uncoated tissue culture flasks. Neurospheres were plated
onto matrigel and immunostained with Ki67, showing proliferating
NPSC (Fig. 2E, F, merged with Hoechst). Human spinal cord
neurospheres expressed high levels of nestin, with nestin positive
fibers emanating radially from the spheres (Fig. 2G-H, arrows).
There was also strong Sox2 immunoreactivity (Fig. 2I–J).
More than 80% of the human spinal cord cells expressed both
nestin and Sox2 (Fig. 3A, nestin 83.664.2%, Sox2 97.163.4%).
2.361.6% of the cells expressed Ki67, and ,2% of the cells
expressed markers of more differentiated cells, GFAP (0.360.07%),
bIII-tubulin (1.460.7%), and O4 (0.460.2%) (Fig. 3A), for
astrocytes, neuronal and oligodendrocyte progenitors, respectively.
Data shown was averaged from cultured cells generated from the
thoracic cord of 3 independent cultures at 35, 66, and 83div. NSPC
generated from the thoracic and lumbar spinal cord showed similar
expression levels of Ki67, nestin, and GFAP (Fig. 3B and D). Fig.3B
wasderived from data averaged from 50and51yearolddonors(34,
66, and 82div), and Fig. 3D data was averaged from a 2 year old
donor (34 and 45div). The most apparent difference was that
cultures from the young donor had a higher mitotic index
(15.1612.5% Ki67) than cultures from the older donors
(2.361.6% Ki67), although this was not statistically significant
(p.0.05). Cultures from the young donor showed higher GFAP
expression (46.165.5%) than the older donors (0.460.2% GFAP)
(p=0.007). Cultures in normoxia or hypoxia showed no significant
differences in Ki67, GFAP, and nestin expression (Fig. 3C).
LIF enhances GFAP expression of adult human spinal
cord NSPC in EGF/FGF2 culture
The addition of 10ug/ml LIF resulted in a 2.5-fold increase in
proliferation of NSPC in normoxia (2.361.6% Ki67 with no LIF
vs. 5.762.1% Ki67 +LIF) (Fig. 4A,B), and a 7-fold increase in
NSPC proliferation in normoxia relative to hypoxia (+LIF:
5.762.1% Ki67 in normoxia vs. 0.860.9% in hypoxia) (Fig. 4B).
There was no significant effect of LIF on Ki67 expression in
hypoxia, and thus the proliferative effect of LIF is attenuated in
hypoxia. Hypoxia alone also had no significant effect on NSPC
proliferation or GFAP expression (Fig. 4A). Most dramatically,
LIF significantly increased GFAP expression (16-fold) in hypoxic
conditions compared to normoxia (+LIF: 56.760.9% GFAP in
hypoxia vs. 3.560.6% in normoxia) (Fig. 4B graph, Fig. 4C-D
immunostaining). These GFAP
+ NSPC also co-expressed nestin,
as shown with double-label immunostaining in Fig. 4F-H.
However, not all nestin
+ cells co-expressed for GFAP, indicating
no cross-reactivity of the GFAP antibody with nestin (Fig. 4F-H).
This suggests that the LIF induced increase in GFAP expression
promoted a radial glial phenotype. This was also suggested by
RC1 immunostaining of some of the cultured cells (Fig. 4E).
Similar staining was observed with 3CB2, another marker for
radial glial cells. In addition, we found that neurospheres formed
in either hypoxia or normoxia in the presence or absence of LIF,
suggesting that neither LIF nor hypoxia are necessary for
neurosphere formation.
Adult human spinal cord NSPC are multipotent and
directed differentiation can be promoted with
exogenous factors
In differentiative conditions in the presence of serum for 4
weeks, adult human spinal cord NSPC demonstrated multi-
potency, differentiating into neurons, as shown with bIII-tubulin
and NF200 staining (Fig. 5A-B), oligodendrocytes (O4, Fig. 5C),
and astrocytes (GFAP, Fig. 5D). However, the percentage of
NSPC differentiation was low, with 1.561.1% bIII-tubulin,
1.160.6% NF200, 1.361.2% O4, 0.160.08% CNPase and
0.260.07% GFAP expression in serum conditions. Also, cell
proliferation and capacity to differentiate into oligodendrocytes
decreased with increased time in culture. For example, the relative
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PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e27079Figure 2. Neurospheres form at clonal density and express stem cell markers. NPSC cultured as an adherent monolayer for 39div were
seeded at clonal density (,10 cells/ml) in EGF/FGF2 medium in suspension culture. A, Image taken on the day of seeding (d0) show single cells
(arrows). B, 7d later neurospheres have formed (arrows). C, NSPC seeded at higher density (1000 cells/ml) at the time of plating form more
neurospheres which are larger (arrows) (D, at 7d). Inset in D shows a high magnification image of a single neurosphere with a phase bright profile and
ciliary projections (arrows). Neurospheres were plated onto matrigel and immunostained with stem cell markers. E-F, A single neurosphere showing
proliferating Ki67
+ NSPC (arrows) (E, green) stained with the nuclear dye Hoechst (F, merged). G-H, Three adjacent neurospheres expressing high
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culture to 0.01% at 4 months in culture. We then investigated the
capacity of exogenous factors to promote directed differentiation
of adult human spinal cord NSPC (from 3 cultures at 46, 58, and
72div). PDGF enhanced oligodendrocyte progenitor proliferation
and differentiation [54-56], and dibutyryl cyclic AMP (dbcAMP)
which is a membrane permeable analog of cAMP enhanced
neuronal differentiation of hippocampal progenitor cells and fetal
rat striatal NSPC [57,58]. Recently, dbcAMP promoted neuronal
differentiation of adult rat brain NSPC [59]. We found that 1 mM
or 4 mM dbcAMP promoted neuronal differentiation of adult
human spinal cord NSPC. With dbcAMP, NSPC showed
increased bIII-tubulin and NF200 expression (Fig. 5E–F), and
displayed enhanced neurite outgrowth and increased network
formation (Fig. 5A–B, E–F). As shown in Fig. 5I, bIII-tubulin
expression in 1 mM dbcAMP significantly increased by 19-fold
relative to control (54.462.1% bIII-tubulin in dbcAMP vs.
2.862.2% in SFM). NF200 expression also significantly increased
15-fold relative to control (21.260.3% NF200 in dbcAMP vs.
1.960.7% in SFM). Fewer cells survived in wells incubated with
dbcAMP suggesting selective death of non-neuronal progeny or
survival of neuronal progenitor cells. PDGF-AA promoted
oligodendrocyte differentiation as shown with increased O4 and
CNPase immunostaining (Fig. 5G-H). Both PDGF and dbcAMP
similarly increased O4 and CNPase immunoreactivity, but this
was not statistically significant from control (Fig. 5I).
Transplantation of adult human spinal cord NSPC into
the injured rat spinal cord
Rats were injured with a moderate clip compression SCI, and
1wk later, NSPC were transplanted rostral and caudal to the lesion
site. At 1wk post-transplantation, adult human spinal cord NSPC
were identified with an antibody against human specific
mitochondrial antigen (hMito) (Fig. 6A, confocal Fig 6B).
Transplanted NSPC were also identified with human specific
nuclear antigen (hNuc) (Fig. 6C), which was used for double-label
Figure 3. Phenotypic expression profile of human spinal cord NSPC in EGF/FGF2 culture. A, NPSC primarily express nestin and Sox2, and
low levels of GFAP, tubulin, and O4. Data shown is averaged from cultured cells generated from the thoracic cord of 3 independent cultures at 35, 66,
and 83div. B, NSPC generated from the thoracic and lumbar spinal cord from 2 cultures (34, 66, and 82div) show similar expression levels. C, NSPC
cultured in normoxic or hypoxic conditions (2 cultures at 45 and 58div) show no significant differences in Ki67, nestin, and GFAP expression. D, NSPC
derived from a younger donor (34 and 45div) also show similar expression levels when cells were generated from the thoracic or lumbar spinal cord.
Cultures from the young donor (D) showed significantly higher GFAP expression than cultures from the older donors (B) (p=0.007).
doi:10.1371/journal.pone.0027079.g003
levels of nestin (G, green) with nestin
+ processes radially emanating from the neurospheres (arrows) (H, merged). I-J, Most NSPC comprising the
neurosphere express Sox2 (I, green; J, merged with Hoechst nuclear counterstain).
doi:10.1371/journal.pone.0027079.g002
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Since the hNuc antibody labels only the nucleus of transplanted
cells it is useful to use in combination with cell type-specific
antibodies to assess double-labelling. In comparison, the hMito
antibody labels the cellular processes, and showed extensive
process extension from the transplanted cells (Fig. 6B). The
average percentage of hNuc
+ grafted cells surviving at 1wk post-
transplantation was 7.664.72%, which is comparable to our
previous studies with subacutely transplanted rat spinal cord
NSPC into the injured cord [13,17]. We did not observe hNuc
+/
Ki67
+ cells (Fig. 6D-F), suggesting that the transplanted cells
became post-mitotic. Ki67
+ cells were often found adjacent to
hNuc
+ transplanted NSPC (Fig. 6F). In the injured rat spinal cord,
transplanted human spinal cord NSPC expressed bIII-tubulin
(Fig. 6G-I), GFAP (Fig. 6J-L), and CC1 (Fig. 6M-O), showing
differentiation into neurons, astrocytes, and oligodendrocytes,
respectively. Thus, adult human spinal cord NSPC survive
following transplantation into the injured rat spinal cord and
differentiated into neurons, astrocytes, and oligodendrocytes.
Discussion
We showed that proliferating and self-renewing NSPC can be
cultured from the adult human spinal cord from organ transplant
donors, and can be passaged as an adherent monolayer in the
presence of EGF and FGF2. Also, these neurospheres can form in
suspension culture at clonal density when the NSPC are initially
cultured as an adherent monolayer. Cells cultured from the adult
Figure 4. LIF enhances GFAP expression of adult human spinal cord NSPC in EGF/FGF2 culture. A, In the absence of LIF (3 cultures at 42,
55 and 66div), there is no significant difference in Ki67 or GFAP expression in normoxic or hypoxic conditions. B, In the presence of LIF (3 cultures at
35, 55, and 66div), there is a significant increase in Ki67 expression in normoxic versus hypoxic conditions (* p,0.025). LIF significantly increases GFAP
expression in hypoxia (** p,0.001). C, GFAP
+ NSPC in hypoxic culture in the absence of LIF. D, There are more GFAP
+ cells in hypoxia + LIF. E, RC1
+
NSPC (39div) in normoxic conditions. F, GFAP
+ cells (arrows) are double-labelled with nestin (G) as shown in the merged panel (H). Arrows show
GFAP
+/nestin
+cells. Arrowheads show GFAP
-/nestin
+cells.
doi:10.1371/journal.pone.0027079.g004
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are a heterogenous population comprised of both stem and more
restricted progenitor cells. To our knowledge, no other group has
reported successful passaging and expansion of adult human spinal
cord-derived NSPC and the transplantation of these cells. We refer
to these cells as a mixed population of neural stem/progenitor cells
since they display properties of self-renewing multipotent stem cells
and more restricted progenitors.
Our initial attempts to culture these NSPC as neurospheres in
suspension culture were unsuccessful, even with the addition of
various factors such as LIF, BIT and hypoxic conditions, which
previous work has shown to increase the expansion of NSPC
[29,33,40,42–45]. Culturing these cells as an adherent monolayer
in EGF/FGF2 supplemented medium was effective in selecting
and expanding the NSPC population. Primary culture from the
adult human spinal cord is very heterogenous, consisting of various
differentiated cells in addition to the precursor cells, myelin and
cell debris. The mitogenic growth factors select for the precursor
cells, and myelin and cell debris are removed with media changes
in an adherent culture.
In EGF/FGF supplemented medium, these NSPC proliferate
and primarily express markers of stem cells such as nestin and
Sox2, and low levels of markers of more differentiated cells such as
BIII-tubulin, O4, and GFAP. Although nestin and Sox2 are also
expressed by reactive astrocytes, it is unlikely that the human
spinal cord cultures are comprised of reactive astrocytes since they
express low levels of GFAP. Also, the expression of nestin and
Sox2 was observed early in culture by the first passage. This
phenotypic expression pattern in proliferative culture conditions is
consistent with our previous work with NSPC derived from the
adult rat spinal cord [11,13], and with other studies with NSPC
from the rodent and human fetal spinal cord [20,31,60,61]. In
Figure 5. Adult human spinal cord NSPC are multipotent and directed differentiation can be promoted with exogenous factors. A-D,
NPSC (from 3 cultures at 46, 58, and 72div) were plated in 1% FBS for 4wk and immunostained with cell type specific markers. NSPC expressed
markers of neurons, bIII-tubulin (A) and NF200 (B), oligodendrocyte progenitor cell marker O4 (C), and GFAP (D) for astrocytes. The addition of
dbcAMP increased the expression of bIII-tubulin (E) and NF200 (F). PDGF increased O4 (G) and CNPase (H) expression. I, Quantitation of % phenotype
of NSPC after 4wk in dbcAMP, PDGF, and FBS or SFM controls. The expression of bIII-tubulin significantly increased in the presence of dbcAMP relative
to SFM controls (** p,0.001). NF200 expression was also significantly increased compared to controls (* p,0.004). There was no significant difference
in the quantitative expression of O4 and CNPase in any of the groups.
doi:10.1371/journal.pone.0027079.g005
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PLoS ONE | www.plosone.org 9 November 2011 | Volume 6 | Issue 11 | e27079Figure 6. Transplantation of adult human spinal cord NSPC into the injured rat spinal cord. Adult human spinal cord NSPC were
transplanted rostral and caudal to the lesion site at 1wk post-SCI. Rats were sacrificed at 1wk post-transplantation and tissue was sectioned in a
parasagittal orientation. A, Low magnification fluorescent image showing transplanted cells (green) identified with human specific mitochondrial
antigen (hMito). Tissue was stained with DAPI nuclear counterstain (blue). B, High magnification confocal image of boxed area showing hMito
+
transplanted cells. C, Low magnification image showing transplanted cells (green) identified with human specific nuclear antigen (hNuc). D-F, Ki67
+
(red) proliferating cells (arrowheads) adjacent to hNuc
+ (green) transplanted cells. G-I, Transplanted NSPC expressing bIII-tubulin (tub); hNuc
+/tub
+
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NPSC proliferation, which is contrary to previous studies [42–45]
perhaps because the other studies used neurospheres from
embryonic or fetal cells. Also, in the present study, the adult
human spinal cord NSPC were maintained and exposed to
hypoxia from the time of isolation. Consistent with our findings,
van der Kooy’s group found that primary colonies derived from
embryonic and adult mouse brain NSPC had little response to
hypoxia [62]. Increased colony formation in hypoxia was only
seen after one or more passages in normoxia [62].
LIF is important for self-renewal of mouse embryonic stem cells
and has increased the rate of proliferation of fetal neural stem cells
[29,39–41]. Consistent with these studies, LIF significantly
increased the proliferation of adult human spinal cord NSPC in
normoxia. However, this effect was not apparent in hypoxia
suggesting that low oxygen abrogates the effects of LIF. LIF also
significantly enhanced GFAP expression in hypoxia, and these
GFAP cells co-expressed nestin. Similarly, LIF was shown to
upregulate GFAP in nestin positive cells cultured from human fetal
cortex [40], and LIF and BMP4 were shown to act synergistically
to induce astrocyte differentiation from human fetal spinal cord
precursors [63]. Other studies have reported the co-expression of
nestin and GFAP in NSPC [22,47,64,65], suggesting that these
cells represent radial glial cells, which are recognized as
multipotent neural stem cells [66–68].
We also showed that adult human spinal cord NSPC are
multipotent, generating neurons, astrocytes, and oligodendrocytes.
However, unlike NSPC from the adult rat spinal cord, human
spinal cord NSPC do not preferentially differentiate into
oligodendrocytes, suggesting a species specific difference in
phenotypic potential. In terms of donor age, human spinal cord
NSPC derived from the younger donor yielded a higher
percentage of neuronal, astrocyte and oligodendrocyte differenti-
ation, although this difference was not marked. Overall, the
capacity for NSPC differentiation diminished with increased time
in culture, consistent with previous reports [18,20,23,26,64,69].
The present study also showed the response of adult human
spinal cord NSPC to exogenous factors which promoted selective
differentiation. DbcAMP enhanced neuronal differentiation,
similar to previous reports with fetal and adult rat brain NSPC
[57–59]. DbcAMP markedly enhanced morphological differenti-
ation of human spinal cord NSPC and their expression of
neuronal markers. Previously, we showed that dbcAMP is one of
the most effective factors in inducing neuronal differentiation of
adult rat brain NSPC [59]. Consistent with our earlier study, the
effects of dbcAMP on the in vitro differentiation of human spinal
cord NSPC were not proliferative, suggesting a selective survival of
neuronal progenitor cells or alternatively, cell death of non-
neuronal progenitor cells. We have not examined whether the
neurons formed from adult human NSPC are interneurons or
motorneurons. Guo et al., showed that a combination of factors
including Shh, retinoic acid, FGF2, and vitronectin promoted the
differentiation of a fetal human spinal cord stem cell line to
motorneurons [70]. Also consistent with our earlier study [59], an
increase in the percentage of NSPC expressing oligodendrocyte
markers in response to dbcAMP was observed. This suggests
pleiotropic actions of dbcAMP on NSPC differentiation which are
not species-specific. PDGF-AA similarly increased oligodendrocyte
differentiation, but this was not statistically significant. This is
consistent with other reports describing limited differentiation of
human fetal NSPC in response to PDGF [20,27,29,31]. Fewer
oligodendrocytes were generated from human embryonic spinal
cord neural precursors relative to rodent cells [20]. We plan to
examine other factors to promote oligodendrocyte differentiation.
The adult human spinal cord NSPC survived after subacute
transplantation into the injured rat spinal cord, and retained the
capacity to differentiate into neurons, astrocytes, and oligoden-
drocytes. Also, the xenografted human NSPC did not express
Ki67 1 week post-transplantation, suggesting they became post-
mitotic. The present study provides a better understanding of
specific factors and conditions that promote adult human NSPC
expansion and differentiation. Also, factors which promote
selective differentiation of human NPSC may be used for the
pre-differentiation of these cells prior to transplantation or the
factors may be administered after grafting to promote targeted
differentiation in vivo. Next, we plan to examine functional
recovery following transplantation of these cells in experimental
SCI. This is the first study to show that self-renewing multipotent
NSPC can be isolated and passaged from adult human spinal
cords from organ transplant donors, and that these cells survive
and differentiate following transplantation into SCI rats. It is
possible that these cells may be useful for transplantation in
humans with SCI or other diseases of the spinal cord. The ease
with which neuronal differentiation can be induced is especially
attractive.
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